000 | 01738 a2200505 4500 | ||
---|---|---|---|
005 | 20250516160520.0 | ||
264 | 0 | _c20140410 | |
008 | 201404s 0 0 ger d | ||
022 | _a1438-8790 | ||
024 | 7 |
_a10.1055/s-0033-1344344 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHaidl, P | |
245 | 0 | 0 |
_a[Effect of Inhalation of Tobramycin for 12 Months on Reduction of Hospitalisation Rate in Severe COPD]. _h[electronic resource] |
260 |
_bPneumologie (Stuttgart, Germany) _cSep 2013 |
||
300 |
_a514-9 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aCausality |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGermany _xepidemiology |
650 | 0 | 4 |
_aHospitalization _xstatistics & numerical data |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPneumonia, Bacterial _xdiagnosis |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdiagnosis |
650 | 0 | 4 |
_aRespiratory System Agents _xadministration & dosage |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aTobramycin _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aAssessment of Medication Adherence |
700 | 1 | _aBargon, J | |
700 | 1 | _aGessler, T | |
700 | 1 | _aPfeifer, M | |
700 | 1 | _aRanderath, W | |
700 | 1 | _aVoshaar, T | |
700 | 1 | _aWachall, B | |
773 | 0 |
_tPneumologie (Stuttgart, Germany) _gvol. 67 _gno. 9 _gp. 514-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-0033-1344344 _zAvailable from publisher's website |
999 |
_c22900891 _d22900891 |